Search Results 341-350 of 4556 for 留痕官网咨询邮箱：lgooxc@hotmail.com
This is a Phase 1, open-label, first-in-human (FIH) dose-escalation study designed to evaluate the safety, tolerability, pharmacokinetics (PK), pharmacodynamics ...
Learn how to request an extension for Benefactor-Funded Research Early-Career Development Awards at Mayo Clinic's Center for Clinical and Translational ...
Fuel groundbreaking medical research! ... Your donation powers the future of medicine and helps save lives. Give Today.
The purpose of this pilot phase study is to assess functionality and ease of use of an exercise monitoring system and decide whether any modifications are ...
In this study the investigators propose to use a daily dose of 45 mg (30 mg at 8 AM and 15 mg at 4 PM). This relatively small well-tolerated dose is likely to ...
Read FAQs and answers about OR-Stretch app technology from the Human Factors Engineering Lab of Susan Hallbeck, Ph.D., at Mayo Clinic.
About this study. The purpose of this study is to characterize healthcare provider experiences caring for Latino/a patients receiving PRS in a Federally ...
About this study. To prospectively collect blood and tumor tissue from esophageal cancer patients to identify specific esophageal cancer mutations that can ...
About this study. The purpose of this study is to examine how IRIS (Intelligent Real-time Image Segmentation) affects biopsy patterns in VLE (Volumetric ...
About this study. The purpose of this study is to evaluate the dose escalation and expansion of RP1 alone and combined with nivolumab in adult subjects with ...
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
Your donation powers the future of medicine and helps save lives.